ISRAEL BIOTECH FUND I, L.P. exercised options at AYALA PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
Common Stock, par value $0.001 per share
Shares
+1.93M
Price / share
$0.40
Trade value
$770.49K
% of position
Common Stock, par value $0.001 per share
Shares
+4.24M
Price / share
$0.40
Trade value
$1.70M
% of position
Common Stock, par value $0.001 per share
Shares
+3.89M
Price / share
$0.40
Trade value
$1.55M
% of position
Common Stock, par value $0.001 per share
Shares
+1.30M
Price / share
$0.40
Trade value
$518.33K
% of position
Common Stock, par value $0.001 per share
Shares
+8.44M
Price / share
$0.40
Trade value
$3.38M
% of position
Common Stock, par value $0.001 per share
Shares
−2.71M
Price / share
$1.25
Trade value
$3.37M
% of position
Common Stock, par value $0.001 per share
Shares
+8.06M
Price / share
$0.40
Trade value
$3.23M
% of position
Common Stock, par value $0.001 per share
Shares
−2.59M
Price / share
$1.25
Trade value
$3.22M
% of position
Net shares
+22.55M
Net value
$4.54M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | M · Option Exercise | +1.93M | $0.40 | $770.49K | 21.1% | 9.12M | 11.04M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | M · Option Exercise | +4.24M | $0.40 | $1.70M | 30.0% | 14.12M | 18.36M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | M · Option Exercise | +3.89M | $0.40 | $1.55M | 35.2% | 11.04M | 14.93M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | M · Option Exercise | +1.30M | $0.40 | $518.33K | 7.1% | 18.36M | 19.66M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | M · Option Exercise | +8.44M | $0.40 | $3.38M | 56.5% | 14.93M | 23.37M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | F · Tax Withholding | −2.71M | $1.25 | $3.37M | 11.6% | 23.37M | 20.66M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | M · Option Exercise | +8.06M | $0.40 | $3.23M | 41.0% | 19.66M | 27.72M |
| Common Stock, par value $0.001 per share Indirect | 2/7/2024 | F · Tax Withholding | −2.59M | $1.25 | $3.22M | 9.3% | 27.72M | 25.13M |
| Total | +22.55M | $4.54M | ||||||
Convertible Promissory Note
Common Stock
1.93M shares
Shares
−1.93M
Strike price
0.40
Held after
13.66M
Exercisable
—
Convertible Promissory Note
Common Stock
4.24M shares
Shares
−4.24M
Strike price
0.40
Held after
19M
Exercisable
—
Convertible Promissory Note
Common Stock
3.89M shares
Shares
−3.89M
Strike price
0.40
Held after
11.72M
Exercisable
—
Convertible Promissory Note
Common Stock
1.30M shares
Shares
−1.30M
Strike price
0.40
Held after
14.76M
Exercisable
—
Warrants
Common Stock
8.44M shares
Shares
−8.44M
Strike price
0.40
Held after
7.84M
Exercisable
—
Warrants
Common Stock
8.06M shares
Shares
−8.06M
Strike price
0.40
Held after
13.46M
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Convertible Promissory Note Indirect | Common Stock1.93M shares | 2/7/2024 | M · Option Exercise | −1.93M | 0.40 | — | 13.66M |
| Convertible Promissory Note Indirect | Common Stock4.24M shares | 2/7/2024 | M · Option Exercise | −4.24M | 0.40 | — | 19M |
| Convertible Promissory Note Indirect | Common Stock3.89M shares | 2/7/2024 | M · Option Exercise | −3.89M | 0.40 | — | 11.72M |
| Convertible Promissory Note Indirect | Common Stock1.30M shares | 2/7/2024 | M · Option Exercise | −1.30M | 0.40 | — | 14.76M |
| Warrants Indirect | Common Stock8.44M shares | 2/7/2024 | M · Option Exercise | −8.44M | 0.40 | — | 7.84M |
| Warrants Indirect | Common Stock8.06M shares | 2/7/2024 | M · Option Exercise | −8.06M | 0.40 | — | 13.46M |